AU2001257406A1 - Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 - Google Patents
Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941Info
- Publication number
- AU2001257406A1 AU2001257406A1 AU2001257406A AU5740601A AU2001257406A1 AU 2001257406 A1 AU2001257406 A1 AU 2001257406A1 AU 2001257406 A AU2001257406 A AU 2001257406A AU 5740601 A AU5740601 A AU 5740601A AU 2001257406 A1 AU2001257406 A1 AU 2001257406A1
- Authority
- AU
- Australia
- Prior art keywords
- cardiovascular
- diagnosis
- compositions
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 231100000588 tumorigenic Toxicity 0.000 title 1
- 230000000381 tumorigenic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19990800P | 2000-04-26 | 2000-04-26 | |
| US60/199,908 | 2000-04-26 | ||
| US63552100A | 2000-08-09 | 2000-08-09 | |
| US09/635,521 | 2000-08-09 | ||
| PCT/US2001/013788 WO2001081634A2 (en) | 2000-04-26 | 2001-04-25 | Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001257406A1 true AU2001257406A1 (en) | 2001-11-07 |
Family
ID=26895283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001257406A Abandoned AU2001257406A1 (en) | 2000-04-26 | 2001-04-25 | Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20040091929A1 (en) |
| EP (1) | EP1280937A2 (en) |
| AU (1) | AU2001257406A1 (en) |
| WO (1) | WO2001081634A2 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030232056A1 (en) | 1999-09-10 | 2003-12-18 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| US6710170B2 (en) | 1999-09-10 | 2004-03-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| AU6531101A (en) * | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US20030120040A1 (en) | 2001-06-29 | 2003-06-26 | Genentech, Inc. | Secreted and Transmembrane polypeptides and nucleic acids encoding the same |
| ATE494550T1 (en) | 2003-04-25 | 2011-01-15 | Takeda Pharmaceutical | NEW SCREENING PROCESS |
| US20080038247A1 (en) * | 2003-05-05 | 2008-02-14 | Bayer Healthcare Ag | Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39) |
| WO2005103283A1 (en) | 2004-04-23 | 2005-11-03 | Takeda Pharmaceutical Company Limited | Novel method of screening |
| AU2005311321A1 (en) * | 2004-12-01 | 2006-06-08 | Janssen Pharmaceutica N.V. | G protein coupled receptor |
| WO2007024752A2 (en) * | 2005-08-26 | 2007-03-01 | Beth Israel Deaconess Medical Center | Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders |
| AR059900A1 (en) | 2006-03-17 | 2008-05-07 | Genentech Inc | ANTI-TAT226 ANTIBODIES AND IMMUNOCATE PLAYERS |
| EP2030024A1 (en) * | 2006-06-08 | 2009-03-04 | Janssen Pharmaceutica N.V. | G protein coupled receptor 39 (gpr39) |
| US20120282230A1 (en) * | 2009-10-21 | 2012-11-08 | Kimberly Drenser | Methods and compositions for diagnosis and treatment of genetic and retinal disease |
| US12268692B2 (en) | 2020-04-10 | 2025-04-08 | Postsurgical Therapeutics, Inc. | Combinatorial targeted therapy methods |
| WO2021207727A1 (en) * | 2020-04-10 | 2021-10-14 | Postsurgical Therapeutics, Inc. | Combinatorial targeted therapy methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2370489A1 (en) * | 1999-04-09 | 2000-10-19 | Human Genome Sciences, Inc. | 49 human secreted proteins |
| CA2402834A1 (en) * | 2000-03-23 | 2001-09-27 | Immusol Incorporated | Brca-1 regulators and methods of use |
-
2001
- 2001-04-25 WO PCT/US2001/013788 patent/WO2001081634A2/en not_active Ceased
- 2001-04-25 AU AU2001257406A patent/AU2001257406A1/en not_active Abandoned
- 2001-04-25 EP EP01930917A patent/EP1280937A2/en not_active Withdrawn
-
2003
- 2003-10-29 US US10/696,706 patent/US20040091929A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001081634A3 (en) | 2002-09-12 |
| US20040091929A1 (en) | 2004-05-13 |
| WO2001081634A2 (en) | 2001-11-01 |
| EP1280937A2 (en) | 2003-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2124397A (en) | Compositions and methods for the treatment and diagnosis of cardiovascular disease | |
| AU2001271973A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
| AU7722600A (en) | Compositions and methods for the diagnosis and treatment of immune disorders | |
| EP0808324A4 (en) | Compositions and methods for the treatment and diagnosis of cardiovascular disease | |
| AU2001249835A1 (en) | Diagnosis and treatment of alzheimer's disease | |
| AU2001249329A1 (en) | Lipoxin analogs and methods for the treatment of periodontal disease | |
| ZA200301204B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| AU5309600A (en) | Compositions and methods for the treatment and diagnosis of immune disorders | |
| AU2001257406A1 (en) | Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 | |
| AUPR101600A0 (en) | Compositions and methods for diagnosis and treatment of cardiovascular disorders | |
| AU8678501A (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
| AU2002222108A1 (en) | Diagnosis and treatment of alzheimer's disease | |
| AU4228000A (en) | Methods and compositions for the treatment and prevention of lung disease | |
| AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
| AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
| AU2002363227A1 (en) | Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 | |
| AU4225500A (en) | Methods and compositions for the treatment and prevention of lung disease | |
| AU2001255168A1 (en) | Compositions and methods for the treatment of immune related diseases | |
| AU2002239505A1 (en) | Methods and compositions for the diagnosis and treatment of viral disease using 55092 | |
| AU2002348324A1 (en) | Methods and compositions for the treatment and diagnosis of pain disorders using 46566 | |
| AU2002232433A1 (en) | Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3 | |
| AU2001241778A1 (en) | Methods and compositions for the diagnosis and treatment of cardiovascular, hepatic, and bone disease | |
| AU2002359316A1 (en) | Methods and compositions for the diagnosis and treatment of hematological disorders using 16319 | |
| AU2002357675A1 (en) | Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |